TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Octapharma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,679,535
|
2,420,530
|
1,972,217 |
| Financial expenses |
26,330
|
121
|
11,301 |
| Earnings before taxes |
104,858
|
182,789
|
79,817 |
| EBITDA |
312,086
|
387,201
|
295,199 |
| Total assets |
2,865,363
|
1,851,898
|
1,332,866 |
| Current assets |
1,424,319
|
673,310
|
420,907 |
| Current liabilities |
465,860
|
384,381
|
339,775 |
| Equity capital |
1,224,896
|
1,177,921
|
965,381 |
| - share capital |
25,782
|
25,326
|
23,648 |
| Employees (average) |
989
|
1,065
|
984 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
42.7%
|
63.6%
|
72.4% |
| Turnover per employee |
2,709
|
2,273
|
2,004 |
| Profit as a percentage of turnover |
3.9%
|
7.6%
|
4.0% |
| Return on assets (ROA) |
4.6%
|
9.9%
|
6.8% |
| Current ratio |
305.7%
|
175.2%
|
123.9% |
| Return on equity (ROE) |
8.6%
|
15.5%
|
8.3% |
| Change turnover |
215,361
|
308,371
|
280,838 |
| Change turnover % |
9%
|
15%
|
17% |
| Chg. No. of employees |
-76
|
81
|
102 |
| Chg. No. of employees % |
-7%
|
8%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.